Evidence map›Paper›PMID 31970512›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

Problem Management Plus in the treatment of mental disorders in patients with multiple myeloma.

Hong Zhang, Dongxiu Zhang, Hailong Lin, Leting Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Adapting a mental health program for people with multiple myeloma and smouldering myeloma: a consumer-informed feasibility study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Symptom distress and fear of progression associated with quality of life in multiple myeloma patients receiving treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hong ZhangThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109th Xueyuanxi Road, Wenzhou, Zhejiang Province, China.
Dongxiu ZhangThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109th Xueyuanxi Road, Wenzhou, Zhejiang Province, China.
Hailong LinThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109th Xueyuanxi Road, Wenzhou, Zhejiang Province, China.
Leting HuangThe Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, 109th Xueyuanxi Road, Wenzhou, Zhejiang Province, China. windflakelin@163.com.ORCID http://orcid.org/0000-0002-5103-7722
Wenzhou Medical University · CN

Funding

Wenzhou Municipal Science and Technology Bureau Y20170107
6 · The paper itself

Abstract

objectivesIn this study, Problem Management Plus (PM+) was used for patients with multiple myeloma (MM), to develop a care model of psychology and quality of life.

methodsForty cases received psychological management (PM+ group), and 40 cases underwent investigation without management (non-PM+ group). Patients were assessed using PSYCHLOPS, WHO DAS 2.0, and HADS (see Supplementary File 1).

resultsThe results showed that the PM+ group showed reductions in Psychological Outcome Profile scores (6.3 ± 2.9) following program completion (preprogram scores: 16.0 ± 1.9, P < .05). The non-PM+ group showed differences between preprogram (16.7 ± 1.8) and postprogram scores (14.8 ± 2.6, P < .05). The effect size of the PM+ group exceeded that of the non-PM+ group (5.1 to 1.0). In the Hospital Anxiety and Depression Scale, the PM+ group showed reductions in anxiety (6.4 ± 1.8) and depression (5.4 ± 0.7) (preprogram scores: 14.7 ± 4.3, P < .05 and 10.9 ± 2.6, P < .05, respectively). In the Hospital Anxiety and Depression Scale, scores for mobility, self-care, getting along, life activities, and participation decreased in the PM+ group following program completion (all P's < .05) but did not decrease in the non-PM+ group (all P > .05).

conclusionThe PM+ strategy could help patients to alleviate symptoms of anxiety and depression and strengthen social support, to aid in the management of problems and improve mental disorders. IMPACT STATEMENT: MM patients often experienced mental disorders and wished to participate in psychosocial interventions; the PM+ strategies should be as a wide to help patients manage their problems and alleviate the symptoms of anxiety and depression.

Indexed as

AnxietyDepressionFemaleHumansMaleMiddle AgedModels, PsychologicalMultiple MyelomaPsychotherapyQuality of LifeSocial SupportAnxietyDepressionInterventionMultiple myelomaProblem Management Plus

Identifiers

PMID31970512
OpenAlexW3001502237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.